TABLE 4.
Model 1 | Model 2 | |||
r | P | r | P | |
ΔLVEF | 0.430 | <0.001 | 0.567 | 0.092 |
ΔLVESV | −0.674 | <0.001 | −0.391 | 0.136 |
ΔLVEDV | −0.304 | 0.138 | 0.088 | 0.677 |
ΔPASP | −0.182 | 0.112 | −0.119 | 0.522 |
ΔE/E′ ratio | −0.075 | 0.670 | −0.483 | 0.704 |
ΔLAVI | −0.045 | 0.705 | −0.643 | 0.094 |
Male | 0.041 | 0.718 | 0.216 | 0.335 |
Hypertension | −0.005 | 0.968 | −0.043 | 0.802 |
Diabetes | 0.173 | 0.131 | 0.101 | 0.610 |
MI | 0.136 | 0.226 | 0.146 | 0.419 |
Δ presented difference value between baseline and follow-up. P values <0.05 were considered statistically significant. Model 1, adjusted for age. Model 2, adjusted for ΔLVEF, ΔLVESV, ΔLVEDV, ΔPASP, ΔE/E′ ratio, ΔLAVI, male, hypertension, diabetes, AF, and MI.
E/E′ ratio, transmitral to mitral annular early diastolic velocity ratio; LVEDV, left ventricle end-diastolic volume.